Carter Martha J.
Insider CIK 1213040 · ALBO Chief Regulatory Officer · AEGR See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 31,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 19,688 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 30,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 62,009 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 65,850 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 15,900 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 3,250 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 23,700 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | U Tender | 2023-03-02 | 2023-03-02 | 3,656 | — | $0 | 3,654 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-23 | 2023-01-23 | 120 | $43.80 | $5.3K | 14,506 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-19 | 2023-01-20 | 938 | $43.90 | $41.2K | 14,626 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-25 | 55,000 | — | $0 | 69,506 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-27 | 55,000 | — | $0 | 69,506 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2022-10-25 | 104 | $19.58 | $2.0K | 15,564 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-22 | 2022-07-25 | 106 | $24.68 | $2.6K | 15,668 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-22 | 2022-04-25 | 103 | $32.92 | $3.4K | 15,774 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-24 | 2022-01-25 | 423 | $24.52 | $10.4K | 15,877 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2022-01-18 | 2022-01-20 | 15,900 | — | $0 | 15,900 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2022-01-18 | 2022-01-20 | 10,800 | — | $0 | 16,300 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-01-21 | 2021-01-25 | 23,700 | — | $0 | 23,700 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2021-01-21 | 2021-01-25 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-11 | 2020-09-15 | 938 | — | $0 | 62,009 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-11 | 2020-09-15 | 9,062 | — | $0 | 3,250 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-09-11 | 2020-09-15 | 10,000 | $40.03 | $400.3K | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-11 | 2020-09-15 | 938 | $29.76 | $27.9K | 10,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-11 | 2020-09-15 | 9,062 | $24.48 | $221.8K | 9,062 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-10 | 2020-09-10 | 688 | — | $0 | 12,312 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-10 | 2020-09-10 | 9,312 | — | $0 | 19,688 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-09-10 | 2020-09-10 | 10,000 | $42.41 | $424.1K | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-10 | 2020-09-10 | 688 | $24.48 | $16.8K | 10,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-10 | 2020-09-10 | 9,312 | $24.04 | $223.9K | 9,312 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-09 | 2020-09-10 | 7,500 | — | $0 | 2,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-09 | 2020-09-10 | 2,500 | — | $0 | 29,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-09 | 2020-09-10 | 7,500 | $19.19 | $143.9K | 7,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-09 | 2020-09-10 | 2,500 | $24.04 | $60.1K | 10,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-09-09 | 2020-09-10 | 7,500 | $38.68 | $290.1K | 2,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-09-09 | 2020-09-10 | 2,500 | $39.82 | $99.5K | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-08 | 2020-09-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-08 | 2020-09-10 | 10,000 | $19.19 | $191.9K | 10,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-09-08 | 2020-09-10 | 10,000 | $45.55 | $455.5K | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-01-21 | 2020-01-23 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2017-08-21 | 2017-08-23 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2017-01-20 | 2017-01-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2016-11-28 | 2016-11-30 | 62,947 | — | $0 | 62,947 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2016-05-09 | 2016-05-11 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2016-05-09 | 2016-05-11 | 26,000 | — | $0 | 26,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-08-04 | 2015-08-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-05-01 | 2015-05-07 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-05-01 | 2015-05-07 | 3,000 | — | $0 | 3,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 27,000 | — | $0 | 27,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-12-31 | 2015-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-04-01 | 2014-04-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-11-01 | 2013-11-05 | 5,000 | — | $0 | 127,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-01 | 2013-11-05 | 5,000 | $82.81 | $414.1K | 1,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-11-01 | 2013-11-05 | 5,000 | $14.84 | $74.2K | 6,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-04-01 | 2013-04-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2013-01-23 | 2013-01-24 | 500 | $27.81 | $13.9K | 1,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2012-03-30 | 2012-04-02 | 1,000 | $14.03 | $14.0K | 1,000 | SEC↗ |